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Abstract: Protein-coated magnetic nanoparticles are promising candidates for various medical
applications. Prior to their application into a biological system, one has to guarantee that the
particle dispersions are free from pathogens or any other microbiologic contamination. Furthermore,
to find entrance into clinical routine, the nanoparticle dispersions have to be storable for several
months. In this study, we tested several procedures for sterilization and preservation of nanoparticle
containing liquids on their influence on the integrity of the protein coating on the surface of these
particles. For this, samples were treated by freezing, autoclaving, lyophilization, and ultraviolet
(UV) irradiation, and characterized by means of dynamic light scattering, determination of surface
potential, and gel electrophoresis afterwards. We found that the UV sterilization followed by
lyophilization under the addition of polyethylene glycol are the most promising procedures for
the preparation of sterilized long-term durable protein-coated magnetic nanoparticles. Ongoing work
is focused on the optimization of used protocols for UV sterilization and lyophilization for further
improvement of the storage time.
Keywords: magnetic nanoparticles; superparamagnetic iron oxide nanoparticles; protein corona;
UV sterilization
1. Introduction
Magnetic nanoparticles (MNP) are interesting tools for a variety of applications for diagnosis and
therapy in medicine [1,2]. Prominent examples are magnetic drug targeting [3,4], magnetic particle
hyperthermia [5,6] or magnetic particle imaging [7,8]. For this purpose, aqueous MNP dispersions
(ferrofluids) have to be administered to the body, which requires a reliable sterilization of the ferrofluids
to exclude any risk for the patient from pathogens within the fluid. Typically, this sterilization is
performed by exposure to ultraviolet (UV) radiation or autoclaving [9].
When injecting MNP into a biological system (e.g., the peripheral blood of a patient), a layer made
of different proteins present in the biological system (serving as a protein source) is formed on the
surface of the MNP—the so-called protein corona [10,11]. This protein layer of a few nanometers [12]
can be divided into a peripheral soft corona and a hard corona on the interface to the particles [13,14].
In our previous investigations [15,16] we could demonstrate that the formation of the corona occurs
within seconds and the corona composition is furthermore influenced by the temperature at which
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corona formation takes place, as well as the duration of particle-protein interaction. It should be recalled
here that for most engineered nanoparticles, their dilution in biological fluids (such as peripheral
blood or fetal bovine serum) leads to particle aggregation [17–19]. It is also known that different
particle properties (e.g., size and surface charge) exhibit an influence on protein corona formation
and the resulting corona composition [20–22]. Furthermore, the protein corona plays a crucial
role for the biological fate of the particles within the body [22–24]. The protein corona affects the
cellular uptake profoundly and has an impact on the cell response, for example, cytotoxicity [25–28].
In a previous investigation we found that the strength of particle-cell interactions, as well as the kinetic
ratio of internalized to adherent MNP in/on the cells, can be controlled by adjusting the amount of
proteins bound to the MNP. Therefore, MNPs were equipped with a protein corona before introducing
them into a biological system [29]. Resulting from all these findings, we conclude that protein-coated
nanoparticles are interesting tools to study the interactions of nanoparticles with biological systems in
in vitro and in vivo experiments.
Similar to the common MNP, the protein-coated MNP also have to be sterilized prior to their
in vitro/in vivo application. For particles smaller than 200 nm sterilization can be obtained by means
of filtration. Unfortunately, this method is not suitable for sterilization of larger particles (>220 nm),
because the membrane cut off for sterile filtration is 220 nm. Furthermore, a method for preservation of
protein-coated MNP is needed, which guarantees storage for several months without an alteration of
the integrity of the protein coating. In previous experiments we found a complete decay of the protein
coating after nine days for storing in the fridge (4 ◦C). Up to now, standard procedures for sterilization
and preservation of proteins are UV sterilization and lyophilization, respectively. Nevertheless, there
are some critical steps which should be considered like freeze-concentration during the initial processes
of lyophilization or secondary structure losses by crosslinking of aromatic groups [30].
In the recent years it was demonstrated that magnetic multicore nanoparticles show very
promising magnetic properties for several medical applications [31]. Since these particles show
a size above 200 nm, a sterilization by means of filtration is not possible. Therefore, the aim of the
herein presented study is to establish procedures which allow a reliable sterilization and preservation
of larger protein-coated MNP without any damaging effect on the integrity of the corona proteins.
For this, protein-coated MNP were prepared as described before [16,32], treated by different procedures
for sterilization and preservation, and characterized afterwards regarding possible damaging effects
on the integrity of the protein coating.
2. Results and Discussion
2.1. Nanoparticle Properties
MNP were prepared by alkaline precipitation. The resulting particles consist of maghemite and
show a mean core diameter of about 10 nm, as confirmed by X-ray diffraction and electron microscopy.
After coating with diethylaminoethyl (DEAE) dextran, the mean hydrodynamic diameter determined
by means of dynamic light scattering is about 190 nm. Therefore, a slight agglomeration of the cores
prior to their protein coating can be assumed. The mean hydrodynamic diameter increased up to
250 nm after serum incubation. This might be due to the additional protein shell on the surface of the
particles. An agglomeration of the particles during serum incubation seems not very probable when
looking at the hydrodynamic diameters, but cannot be excluded completely. A second indication for a
successful protein coating is the surface charge of the particles, which turned from +60 mV to −30 mV
for particles prior and after incubation, respectively.
These protein-coated particles were treated by different procedures for preservation and
sterilization. The following sections describe the results of the particle characterization concerning
their hydrodynamic size, surface charge, and the integrity of the protein coating after treatment; see
Table 1.
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Table 1. Summary of applied treatments and methods used for characterization. Dynamic light scattering
(DLS); zeta potential (ZETA); sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE).
Treatment Condition Duration
Analysis
DLS ZETA SDS-PAGE
Preservation
Freezing (−15 ◦C) up to 6 weeks X X X
Deep-Freezing (−80 ◦C) up to 6 weeks X X X
Lyophilization up to 6 weeks X X X
Sterilization
Autoclaving before/after X X X
UV-Sterilization before/after X X X
2.2. Freezing
Protein-coated MNP were frozen under two commonly used freezing conditions, at −15 ◦C
(samples assigned “F”) and −80 ◦C (samples assigned “DF”). Protein-coated MNP samples were
stored for one day (1d), two days (2d), one week (1w), two weeks (2w), four weeks (4w) or six weeks
(6w). After thawing, samples were characterized immediately.
2.2.1. Freezing at −15 ◦C
The visual evaluation of the thawed samples showed that for storing times of two weeks and
longer a significant change in the rheology of the fluid occurs. Larger agglomerates can be found in
the samples and the viscosity decreases. These observations are confirmed by dynamic light scattering
(DLS) measurements (Figure 1a). The original sample, F-0, as well as F-1d, shows a hydrodynamic
diameter of about 260 nm. This value increased to 340 nm for F-2w and in F-6w agglomerates larger
than 1000 nm can be detected. Furthermore, the polydispersity index (PDI) increased with the particle
size simultaneously.
Despite the zeta potential provided a constant value of about −30 mV for all samples, it became
obvious from the size measurements that, during the storage of the samples at a temperature of
−15 ◦C, after two weeks a significant alteration of the integrity of the protein coating takes place.
This assumption was confirmed by gel electrophoresis (SDS-PAGE).
Since the SDS-PAGE has to be carried out immediately after thawing of the samples, it was
not possible to investigate all samples in parallel on one gel. Therefore, different runs of SDS-PAGE
were performed during the study and the plots of the obtained lanes were merged (Figure 1b).
The detailed investigation of the three groups of proteins contributing to the coating was defined:
<30 kDa; 30–100 kDa; >100 kDa. The proportion of each group on the protein coating was calculated
from an analysis of the grey value distribution in the raw greyscale image by means of ImageJ.
The normalized optical grey value analysis by means of ImageJ shows a similar behaviour of the
samples as observed by DLS (Figure 1c). Starting with sample F-2w, an increase of the amount of
smaller proteins (<30 kDa) can be observed. For samples F-4w and F-6w a pronounced amount of
the smaller proteins is present in the protein corona and the proportion of large proteins >100 kDa
decreases. This behaviour can be interpreted as a degradation of the larger proteins to smaller
fragments, which means a decay of the protein coating on the surface of the MNP. The degradation of
the protein corona may then progressively liberate the metal core surface of the nanoparticles, and
thus agglomeration is facilitated when these free metal sites come in contact [33].
In summary, freezing at −15 ◦C is not suitable for the long-term storage of protein-coated MNP.
Short-term storage for up to one week might be possible.
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Figure 1. Freezing of protein-coated nanoparticles at −15 ◦C causes agglomeration during long-term
storage. (a) DLS measurements exhibit a continuous increase of the hydrodynamic diameter with
extended storage times; (b) Protein size distribution is shifted towards smaller sizes after several
weeks of storage demonstrated by gel electrophoresis (silver staining and false color representation);
(c) Variations of the protein size ranges over the storage period (based on (b)). n = 3, M—protein
size marker.
2.2.2. Deep-Freezing at −80 ◦C
Similar to the freezing experiments, deep-freezing caused an agglomeration of the MNP. Starting
from a mean hydrodynamic diameter in DLS of 250 nm for the original sample (F-0), for all samples,
but especially for longer storage times (two and six weeks) the occurrence of larger agglomerates was
observed (Figure 2a). Furthermore, the zeta potential remained in the range from −29 mV to −30 mV
for all samples indicating no alteration of the integrity of the protein coating.
For the investigation of the protein composition by means of SDS-PAGE, similar effects to those
for freezing at −15 ◦C were observed. For storage times longer than two weeks, a significant alteration
of the integrity of the protein coating was detected (Figure 2b and 2c).
In summary, the deep-freezing and storage of the samples at −80 ◦C revealed results similar to
that at−15 ◦C. An agglomeration of protein-coated MNP was observed for storage at−80 ◦C similar to
storage at−15 ◦C, and a remarkable alteration of the protein composition was proven for storage times
of more than two weeks. Therefore, both the freezing and deep-freezing-based treatments presented
here are no suitable procedures for the long-term storage of protein-coated MNP.
It remains to be seen whether a controlled automated freezing and thawing procedure as it is
used for long-term storage of stem cell transplants may improve the outcome of long-term storage [34].
However, these procedures are very complicated and expensive.
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Figure 2. Deep-freezing of protein-coated nanoparticles at −80 ◦C affects the integrity of the protein
corona during long-term storage. (a) DLS measurements confirm the occurrence of larger agglomerates
with extended storage times; (b) Protein size distribution is shifted towards smaller sizes after several
weeks of storage demonstrated by gel electrophoresis (silver staining and false color representation);
(c) Variations of the protein size ranges over the storage period (based on (b)). n = 3, M—protein
size marker.
2.3. Lyophilization
The protein-coated MNP samples were freeze-dried in the condition as prepared (samples
assigned “Plain”) and after addition of polyethylene glycol (PEG; samples assigned “PEG”) or
tetramethylammonium hydroxide (TMAH; samples assigned “TMAH”). PEG was used because
it is suggested as cryoprotectant in combination with sugars [35]. The inherent sugars in serum were
expected to be sufficient for this approach. After lyophilization, the dry powders were re-dispersed
after one week (1w), three weeks (3w), or six weeks (6w) and characterized immediately.
For all three different re-dispersion time points a similar behavior in particle size and
agglomeration was found in each single sample series (Plain, PEG, TMAH). The PEG samples show
a similar size and size distribution after re-dispersion for all re-suspension time points like the original
sample before drying. The Plain samples exhibit for all re-suspension time points a weak proportion
of not re-dispersed agglomerates, and thus a slightly higher mean hydrodynamic diameter and
PDI. When using TMAH as an additive, for all time points of re-suspension a large proportion of
agglomerates remains after re-dispersion and the fluid is not stable against sedimentation, but also
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a certain fraction of very small fragments can be found in the sample (Figure 3a). This is due to the
solubilizing activity of TMAH [36].
Figure 3. Lyophilization of protein-coated nanoparticles affects the integrity of the protein corona
during long-term storage. (a) After storage of the dry powders for six weeks the DLS measurements
show that the hydrodynamic diameter of re-suspended Plain and polyethylene glycol (PEG) samples
is very similar to that of the original sample, but for tetramethylammonium hydroxide (TMAH) an
agglomeration results; (b) Proteins are degraded during lyophilization, especially in the presence of
TMAH, resulting in smaller sizes after several weeks of storage demonstrated by gel electrophoresis
(silver staining and false color representation); (c) Variations of the protein size ranges over the storage
period (based on (b)). n = 3, M—protein size marker.
The analysis of the zeta potential revealed a constant value of about −30 mV for the original and
all “Plain” and “PEG” samples of different storage times, whereas the zeta potential of all “TMAH”
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samples was in the range of −42 to −44 mV. From this zeta potential results an alteration of the protein
integrity due to the addition of TMAH can be supposed.
Protein analysis showed that for a storage time of one week no remarkable changes in the
integrity of the protein coating can be observed for “Plain” and “PEG” samples (Figure 3b and 3c).
For TMAH-treated samples, already after one week an alteration of the protein integrity was observed.
The amount of small proteins (<30 kDa) increased and the amount of larger proteins decreased, which
is an indication for the degradation of the protein coating on the surface of the MNP. After a three-week
storage period both, the sample Plain-3w and PEG-3w exhibit an increase in the low molecular weight
fraction; nevertheless, the protein distribution remains unchanged.
After a storage time of six weeks, partial degradation of the larger proteins occurs and,
in consequence, the fraction of small protein fragments and peptides increases. This might be due
to stressors like freeze-concentration or pH-shift [37]. Furthermore, the large standard deviation in
means of protein size distributions over repetitive experiments implies the pronounced variability in
protein sizes upon re-dispersion of long-term stored samples.
In summary, the lyophilization of protein-coated MNP is a suitable method for the preservation of
such particles for durations of up to one week. The re-dispersion of the dry powders can be improved
by the addition of PEG prior the lyophilization. This phenomenon may be due to the increased stability
of the protein-coated nanoparticles and the reduction of agglomeration [38]. For storage times longer
than one week a partial degradation of the corona proteins can be observed.
2.4. Autoclaving
For the sterilization of protein-coated MNP by means of autoclaving, two groups of samples were
prepared: samples without autoclaving (A-0) and autoclaved samples (A-1). The mean hydrodynamic
diameter of 278 nm for A-0 decreased to 218 nm for the autoclaved samples A-1 (Figure 4a). The PDI
decreased from 0.32 (A-0) to 0.24 (A-1) after the autoclaving process. On the one hand, this result
might be interpreted as a decrease of the thickness of the protein corona due to coagulation of the
proteins, which leads to a higher density of the proteins and thus a lower volume [39].
Figure 4. Autoclaving of protein-coated nanoparticles affects the protein corona dramatically. (a) DLS
measurements show that the hydrodynamic diameter of the protein-coated nanoparticles decreases
during treatment (b) Proteins are degraded during autoclaving demonstrated by gel electrophoresis
(silver staining and false color representation). n = 3, M—protein size marker.
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However, on the other hand, the observed changes in the analyzed parameter sets are in a similar
range as those for the UV radiation exposure experiments. Therefore, the described changes in
hydrodynamic particle sizes and particle size distributions are considered as not significant. A constant
zeta potential of −31 mV for A-0, as well as A-1, was determined. Thus, the obtained results give no
indication for a loss of protein content or alteration of protein integrity during autoclave sterilization
of protein-coated MNP.
The interpretation that the components of the protein corona form a denser layer after autoclaving
is supported by the SDS-PAGE results. After autoclaving the protein bands are no longer clearly
separable but appear as a smear, especially in the high-molecular weight area (Figure 4b). The untreated
sample (A-0) shows the typical pattern containing distinct protein bands for fetal bovine serum
(FBS)-coated MNP, whereas the autoclaved sample (A-1) is mainly blurred and diffuse. All of the
typical peaks are vanished, and only one agglomeration in the region of 55 kDa can be observed.
Beside putative coagulation of the corona proteins, the denaturation and extensive degradation of the
proteins may also contribute to these results.
In conclusion, the standard autoclaving protocol is not suitable for the sterilization of
protein-coated MNP since the stability and integrity of the corona proteins is impaired.
2.5. UV Sterilization
The investigation of the samples without UV treatment (UV-0), samples with 150 min exposure
time (UV-150), and samples with 240 min exposure time (UV-240) revealed no considerable changes in
the mean hydrodynamic particle size, particle size distribution, as well as zeta potential due to the UV
radiation (Figure 5a). The hydrodynamic particle size decreased from 257 nm for UV-0 to 218 nm for
UV-150 and to 189 nm for UV-240. It seems that exposure of protein-coated MNP to UV radiation led
to a reduction of the protein amount on particles surface with increasing exposure time. Since this
hypothesis was not confirmed by the following characterization steps, the observed size decrease
cannot be explained by protein degradation. Another reason for the decreasing particle size due to
UV treatment might be a radiation-induced compaction of the proteins, as previously described by
Durchschlag [39–41]. For the particle size distribution of all three samples a PDI in the range of 0.23 to
0.33 was determined. This indicates a relatively broad distribution of hydrodynamic diameters of the
samples, which might be the reason for the observed variation in the mean particles sizes, too. For all
three samples a zeta potential of about −30 mV was determined. All these measurements of physical
properties indicate that there is no influence of UV exposure on protein amount on the surface of the
MNP. This was confirmed by SDS-PAGE (Figure 5b,c).
Neither in the raw true-color image nor in the pseudo color greyscale image an evidence for any
UV radiation-caused damage of the proteins could be observed. The pattern of the original sample
(UV-0) and the patterns of the samples exposed to UV radiation (UV-150 and UV-240) looked very
similar and showed their maximum intensities between 50 and 70 kDa, which is the typical range for
albumin and its derivatives. The detailed investigation of the three groups of proteins contributing to
the coating was defined: <30 kDa; 30–100 kDa; >100 kDa. The proportion of each group on the protein
coating was calculated from an analysis of the grey value distribution in the raw greyscale image by
means of ImageJ. In Figure 5c it is clear to see that in the frame of measurement accuracy, the samples
before and after UV exposure revealed a comparable size distribution of the corona proteins.
In conclusion, the exposure of a protein coating on MNP to UV radiation of 200–280 nm for up to
240 min causes no relevant change of protein content and integrity. Thus, the applied UV sterilization
regime is suitable for the sterilization of protein-coated MNP.
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Figure 5. Ultraviolet (UV) sterilization of protein-coated nanoparticles does not affect the protein corona.
(a) DLS measurements show that the hydrodynamic diameter of the protein-coated nanoparticles
decreases with increasing treatment time (b) Protein size distribution is not altered as demonstrated
by gel electrophoresis (silver staining and false color representation). (c) Variations of the protein size
ranges over the storage period (based on (b)). n = 3, M—protein size marker.
3. Materials and Methods
3.1. Particle Preparation
The magnetic cores of the nanoparticles introduced in this paper were prepared similar to the
well-known wet chemical precipitation methods [42,43], but using another alkaline medium and a slower
reaction velocity. In detail, a 1 M NaHCO3 solution was slowly added under permanent stirring to
a FeCl2/FeCl3 solution (total Fe-concentration: 0.625 M; Fe2+/Fe3+ ratio = 1/1.3). This procedure
was stopped when the pH value reached 8. During this routine a brownish precipitate was formed.
This precipitate was heated to 100 ◦C for 5 min and iron oxides with a spinel structure were formed under
the release of CO2. To remove excess reaction products from the prepared particles they were washed with
de-ionized water three times [44]. Nanoparticles were stored in de-ionized water at room temperature (RT).
For preparation of protein-coated MNP, the magnetic cores have to be incubated in a natural
protein source, which leads to an accumulation of proteins on the surface of the MNP. For our studies,
fetal bovine serum (FBS) was used as natural protein source. FBS was obtained from Biochrom GmbH
(Berlin, Germany) (#S0115, Lot 1184C, tested for mycoplasma and viruses, tested for endotoxins) FBS
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was heat-inactivated at 56 ◦C for 1 h prior to use. FBS incubation of MNP was performed by water bath
heating resulting in a homogeneous temperature distribution throughout the sample. For this, FBS
was tempered at 37 ◦C in the water bath. A 15 mg pellet of prepared MNP from previously prepared
suspensions was filled up with 2 mL of tempered FBS and kept at the same temperature for 10 min.
During the time of incubation ultra-sonic treatment at the given temperature was carried out (S100H,
Elmasonic, Singen, Germany) to re-disperse possible agglomerates. After 10 min the suspensions were
taken out of the water bath and put on a magnet for magnetic separation, excess FBS was withdrawn
and distilled water was added. The washed incubated nanoparticle suspensions were kept at 4 ◦C for
short term storage prior to the following experiments [16].
3.2. Sterilization and Preservation
For a potential application of the protein-coated MNP in animals or human, one has to guarantee
that the particles are free from biological pathogens or any biological contamination. After the
sterilization it is important, to bring the particles into a condition which makes them storable for
several weeks. For this purpose, freezing, lyophilization, autoclaving, and UV sterilization was applied
to the protein-coated MNP. The following sections describe the applied procedures in more detail.
3.2.1. Freezing
Freezing is a well-established procedure for the preservation of food but also of biological material.
At low temperatures, the reproduction of bacteria is slowed and comes to a standstill at temperatures
below 4 ◦C [45]. To check the influence of temperature on the integrity of the corona proteins after
freezing preservation, the samples were frozen at −15 ◦C (freezing) and −80 ◦C (deep-freezing). Since
the freezing time of the whole sample is a function of the temperature, freezing of the samples takes
longer than deep-freezing. It is expected, that the freezing at −15 ◦C thus leads to the formation of
larger ice crystals which might damage the integrity of the protein coating.
For this investigation, each time six samples of protein-coated MNP suspension of 1 mL were
frozen at the two different temperatures and stored at the desired temperature for up to six weeks.
After defined storage periods (1 day, 2 days, 1 week, 2 weeks, 4 weeks, 6 weeks) the frozen samples
were thawed at RT and characterized immediately.
3.2.2. Lyophilization
Lyophilization is also a well-established procedure for the long-term preservation of liquid
protein-based pharmaceutical formulations [46]. During lyophilization, the sample is frozen at low
temperature and, due to sublimation taking place at vacuum, water within the sample is removed.
This leads to a complete cessation of all vital functions, as well as the reproduction of the pathogens
since they need aqueous conditions to survive. After storage and before using the formulation, water is
added again and after re-dispersion of the samples they should show the same properties like before.
To investigate the influence of additives on the re-dispersion of the lyophilized samples, two
different substances were added before lyophilization: tetramethylammonium hydroxide (TMAH)
or polyethyleneglycol (PEG). After the lyophilization, the dry samples were stored at 4 ◦C and after
certain storage periods (1 week, 3 weeks, 6 weeks) the samples were re-dispersed and the obtained
suspensions characterized. For the re-dispersion, 1 mL of water was added and the samples were
vortexed and treated with ultrasound.
3.2.3. Autoclaving
For the sterilization of protein-coated MNP by means of autoclaving, a standard protocol was
used [47]. For this, 1 mL of the protein-coated MNP suspension was placed into a Varioklav 25 T
(Thermo Fisher Scientific, Waltham, MA, USA) and exposed to a temperature of 121 ◦C for 20 min
at a pressure of 3 bar. This increased temperature leads to protein denaturation and damage of the
DNA of potentially existing pathogens and causes their die-off. After a defined cooling down of the
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samples after the sterilization procedure, the samples were stored for some hours at 4 ◦C prior to
their characterization.
3.2.4. UV Sterilization
For the sterilization procedure, 1 mL of the protein-coated MNP fluid was exposed to a broadband
UV-C radiation in the wavelength range from 200 to 280 nm. The optimum wavelength for the damage
of nucleic acids, and thus the DNA of the pathogens, is 254 nm [47]. This DNA damage kills all
potentially existing pathogens in the sample.
The exposure time was adjusted for a first sample to be 150 min representing the minimum
time for the sterilization, and for a second sample to be 240 min, representing a treatment time for
sterilization including a safety margin. After the UV sterilization, the samples were stored for some
hours at 4 ◦C prior to their characterization.
3.3. Particle Characterization
The magnetic properties were measured by vibrating sample magnetometry (VSM; Micromag
3900, Princeton Measurement Systems, Princeton, NJ, USA). Measurements were performed on liquid
samples or dried powders. Concentration of MNP within the liquid samples and amount of proteins
bound to particle surface were calculated from the obtained saturation magnetization. The overall
magnetic behavior of the samples was derived from coercivity and relative remanence.
DLS was used to obtain information about degradation, agglomeration, or cross-linking of the
protein-coated MNP due to the treatment for sterilization or preservation the MNP by investigating
the size distribution of the particles. For these measurements, a Zetasizer (nanoZS, Malvern, UK) and
appropriate software (Version 6.20) were used and particles’ size was derived from intensity-weighted
scattering. Before the measurement, samples were diluted with a ratio of 1:30 in de-ionized water and
treated in an ultrasonic bath. The medium viscosity and the relative dielectric constant were taken
from water at 25 ◦C with 0.8872 cP and 78.5 cP, respectively. Measurements were performed in three
consecutive runs and obtained values were averaged.
As shown before, the surface charge of protein-coated MNP might serve as an indicator for surface
protein amount and composition [32]. Therefore, we used this parameter for a first check, whether
the protein corona was influenced from the procedures to sterilize and preserve the corona coating.
To determine the surface charge of the protein-coated MNP, the zeta potential is a valid and widely
used parameter. For this, the Zetasizer was used again.
To evaluate, if the sterilization and preservation procedures damage the protein corona coating,
the composition of the protein corona has to be determined before and after the treatment, respectively.
The evaluation of the protein corona composition was carried out by means of SDS-PAGE, as described
previously [32]. In brief, MNP samples were mixed with 4× XT Sample Buffer and 20× Reducing
Agent (both from Bio-Rad, Munich, Germany) and heated up to 95 ◦C for 5 min to crack secondary and
tertiary structure of proteins. Then, the denatured proteins were separated by molecular weight with
polyacrylamide gel electrophoresis on a 4–12% Bis-Tris gel (Bio-Rad, Munich, Germany). After the
run, the proteins were visualized by highly sensitive silver staining (SilverXpress Silver Staining Kit,
Invitrogen, Heidelberg, Germany). Gel images were processed and analyzed by ImageJ (National
Institutes of Health, Bethesda, MD, USA) [48]. As references, a molecular weight standard protein
collection Kaleidoscope marker (Bio-Rad, Munich, Germany) and untreated FBS were used. Since the
SDS-PAGE has to be carried out immediately after thawing or resuspension of the samples, it was
not possible to investigate all samples in parallel on one gel. Therefore, different runs of SDS-PAGE
were performed during the study and the plots of the obtained lanes were merged. The images of the
original gels are provided in the Supplementary Materials, Figures S1–S6: images from the original
silver-stained SDS-Polyacrylamide gels and corresponding false-color images.
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4. Conclusions
With our investigations we could show that freezing at −15 ◦C allows storage of protein-coated
MNP for up to one week. After that, a remarkable degradation of the larger proteins in combination
with an agglomeration of the particles takes place. For deep-freezing at −80 ◦C agglomeration was
observed, too, but also a degradation of the larger proteins after two weeks. The application of tightly
controlled freezing procedures may achieve longer storability in the future. The addition of PEG
to the samples prior to their lyophilization leads to well-dispersed fluids after re-suspension of the
dry powders. Unfortunately, for storage times longer than one week a degradation of the proteins
was observed. This storage period might be extended by using optimized storing conditions (e.g.,
lower temperature, oxygen exclusion, reduced humidity). Autoclaving by using a standard protocol
embedded in a commercially available instrument is not suitable for the sterilization of protein-coated
MNP since it damages the integrity of the protein coating dramatically. For the sterilization by means
of UV radiation, we found no damaging effects for protein-coated MNP.
In our experiments, we were very strict about the assessment of the alteration of the integrity of the
protein coating. Even slight variations of the protein banding patterns elucidated by SDS-PAGE were
interpreted as an alteration of the protein composition already, because they may be the consequence
of disintegration or degradation and thus affect biological properties. This led us to calculate relatively
short storage times without any visible change of the integrity of the protein coating. In prospective
clinical applications such minor changes of the protein integrity may influence the interaction of the
protein coating with the biological surrounding. Therefore, future studies are necessary to elucidate the
treatment-dependent changes on the protein corona, as well as on the single protein level with regard
to cytotoxicity and immunogenicity. Furthermore, the activity of enzymes as well as the availability of
adaptor molecules and ligands has to be investigated in detail. Ongoing studies with cell-based and
in vivo systems are focusing on this topic.
In conclusion, we state that the UV sterilization followed by lyophilization under addition of PEG
are the most promising procedures for the preparation of sterilized long-term durable protein-coated
MNP beyond the sterile filtration limit of 220 nm, see Table 2. The aim of the ongoing work is the
optimization of the established protocols for UV sterilization and lyophilization in order to further
improve the stability of the protein corona and the storage periods.
Table 2. Summary of treatment methods and their suitability for sterilization and preservation of
protein-coated magnetic nanoparticles.
Method Suitable for Application Remarks
UV-Sterilisation yes no major changes
Lyophilization yes, with PEG as additive degradation of large proteins with TMAH
Freezing (−15 ◦C) only for short term storage agglomeration of MNP,degradation of large proteins
Deep-freezing (−80 ◦C) only for short term storage agglomeration of MNP,degradation of large proteins
Autoclaving no degradation of proteins
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/7/12/453/s1,
Figures S1–S6: Original SDS-Polyacrylamide gels and false-color images.
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